News

Filter

Current filters:

None

8130 to 8139 of 95953 results

Emergent considers options as Abbott ends drug R&D collaboration

30-12-2011

Shares of USA-based Emergent BioSolutions (NYSE: EBS) saw its shares fall 4% to $16.53 after the company…

Abbott LaboratoriesEmergent BioSolutionsLicensingOncologyPharmaceuticalResearch

Alexion to buy Enobia Pharma for potential $1 billion

30-12-2011

US drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) has reached agreement to acquire privately held Canadian…

Alexion Pharmaceuticalsasfotase alfaEnobia PharmaMergers & AcquisitionsPharmaceuticalRare diseases

Apricus Biosciences closes Topotarget USA acquisition

30-12-2011

Apricus Biosciences (Nasdaq: APRI) has closed its previously-announced acquisition of Topotarget USA,…

Apricus BioscienceMergers & AcquisitionsOncologyPharmaceuticalTopotargetTotect

Spanish pharma sales down 3.1% in October

30-12-2011

Data from Spain’s Ministry of Health, Social Policy and Equality shows that, in October 2011, public…

EuropeGenericsMarkets & MarketingPharmaceuticalPricingResearch

UCB and Immunomedics amend epratuzumab accord

29-12-2011

New Jersey, USA-based Immunomedics (Nasdaq: IMMU) and Belgian drugmaker UCB (Euronext Brussels: UCB)…

epratuzumabImmunologicalsImmunomedicsLicensingPharmaceuticalRare diseasesUCB

Australia’s Pharma industry economic impact up by A$1 billion

29-12-2011

The Australian pharmaceutical industry’s contribution to the economy grew by an estimated A$1 billion…

Asia-PacificMarkets & MarketingPharmaceuticalResearch

Baxter taps Momenta expertise on biosimilars

28-12-2011

In another move to capitalize on the anticipated flood of biosimilars coming to the market, as blockbuster…

Baxter InternationalBiotechnologyGenericsLicensingMomenta PharmaceuticalsResearch

8130 to 8139 of 95953 results

Back to top